Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy

被引:243
作者
Winkler, DT
Bondolfi, L
Herzig, MC
Jann, L
Calhoun, ME
Wiederhold, KH
Tolnay, M
Staufenbiel, M
Jucker, M
机构
[1] Univ Basel, Inst Pathol, Dept Neuropathol, CH-4003 Basel, Switzerland
[2] Mt Sinai Sch Med, Kastor Neurobiol Aging Labs, New York, NY 10029 USA
[3] Novartis Pharma Ltd, Nervous Syst Res, CH-4002 Basel, Switzerland
关键词
cerebral amyloid angiopathy; hemorrhage; stroke; bleeding; Alzheimer's disease; amyloid; amyloid precursor protein; smooth muscle cells; mouse; brain; CNS;
D O I
10.1523/JNEUROSCI.21-05-01619.2001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A high risk factor for spontaneous and often fatal lobar hemorrhage is cerebral amyloid angiopathy (CAA). We now report that CAA in an amyloid precursor protein transgenic mouse model (APP23 mice) leads to a loss of vascular smooth muscle cells, aneurysmal vasodilatation, and in rare cases, vessel obliteration and severe vasculitis. This weakening of the vessel wall is followed by rupture and bleedings that range from multiple, recurrent microhemorrhages to large hematomas. Our results demonstrate that, in APP transgenic mice, the extracellular deposition of neuron-derived beta -amyloid in the vessel wall is the cause of vessel wall disruption, which eventually leads to parenchymal hemorrhage. This first mouse model of CAA-associated hemorrhagic stroke will now allow development of diagnostic and therapeutic strategies.
引用
收藏
页码:1619 / 1627
页数:9
相关论文
共 50 条
  • [41] Aβ-related cerebral amyloid angiopathy
    O. Bugiani
    Neurological Sciences, 2004, 25 : s1 - s2
  • [42] Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease
    Robbins, EM
    Betensky, RA
    Domnitz, SB
    Purcell, SM
    Garcia-Alloza, M
    Greenberg, C
    Rebeck, GW
    Hyman, BT
    Greenberg, SM
    Frosch, MP
    Bacskai, BJ
    JOURNAL OF NEUROSCIENCE, 2006, 26 (02) : 365 - 371
  • [43] Cerebral Amyloid Angiopathy - An Update
    Gahr, M.
    Nowak, D. A.
    Connemann, B. J.
    Schoenfeldt-Lecuona, C.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2012, 80 (11) : 618 - 626
  • [44] Cerebral amyloid angiopathy - A review
    Opeskin, K
    AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY, 1996, 17 (03) : 248 - 254
  • [45] Cerebral amyloid angiopathy: An overview
    Yamada, M
    NEUROPATHOLOGY, 2000, 20 (01) : 8 - 22
  • [46] UBIQUITIN IN CEREBRAL AMYLOID ANGIOPATHY
    CRUZSANCHEZ, FF
    MARIN, C
    ROSSI, ML
    CARDOZO, A
    FERRER, I
    TOLOSA, E
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1992, 112 (1-2) : 46 - 50
  • [47] Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy
    Love, Seth
    Miners, Scott
    Palmer, Jen
    Chalmers, Katy
    Kehoe, Patrick
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 4778 - 4792
  • [48] The Pathophysiology and Clinical Presentation of Cerebral Amyloid Angiopathy
    Auriel, Eitan
    Greenberg, Steven Mark
    CURRENT ATHEROSCLEROSIS REPORTS, 2012, 14 (04) : 343 - 350
  • [49] The prevalence of radiological cerebral amyloid angiopathy-related inflammation in patients with cerebral amyloid angiopathy
    Amin, Moein
    Aboseif, Albert
    Southard, Kristopher
    Uchino, Ken
    Kiczek, Matthew
    Hajj-Ali, Rula
    Kharal, G. Abbas
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2023, 32 (12)
  • [50] Severe pathological manifestation of cerebral amyloid angiopathy correlates with poor outcome from cerebral amyloid angiopathy related intracranial hemorrhage
    Tang Ya-juan
    Wang Shuo
    Zhu Ming-wei
    Sun Yi-lin
    Zhao Ji-zong
    CHINESE MEDICAL JOURNAL, 2013, 126 (04) : 603 - 608